MANUFACTURING OF DIMERIC CONTRAST AGENTS

The invention relates to a process for the preparation of dimeric contrast agents foruse in Magnetic resonance Imaging (MRI), in particular [μ-[1-[bis[2-(hydroxy-κO)-3-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN

Saved in:
Bibliographic Details
Main Authors BUONSANTI, Federica, GAZZETTO, Sonia, BANIN, Andrea, BARALE, Andrea, BOI, Valeria
Format Patent
LanguageEnglish
Published 16.11.2023
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The invention relates to a process for the preparation of dimeric contrast agents foruse in Magnetic resonance Imaging (MRI), in particular [μ-[1-[bis[2-(hydroxy-κO)-3-[4,7,10-tris[(carboxy-κO)methyl]-1,4,7,10-tetraazacyclododec-1-yl-κN
Bibliography:Application Number: AU20220317221